Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: a prospective multicentre study
Background TNF-like weak inducer of apoptosis (TWEAK) is a proinflammatory molecule that plays a key role in active inflammation of lupus nephritis (LN). Urine TWEAK (uTWEAK) levels were found to be associated with renal disease activity among patients with LN. Here, we determined whether serial mea...
Saved in:
| Main Authors: | Thitima Benjachat Suttichet, Wonngarm Kittanamongkolchai, Chutipha Phromjeen, Sirirat Anutrakulchai, Thanachai Panaput, Atiporn Ingsathit, Nanticha Kamanamool, Vuddhidej Ophascharoensuk, Vasant Sumethakul, Yingyos Avihingsanon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-12-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/6/1/e000298.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis
by: Wonngarm Kittanamongkolchai, et al.
Published: (2024-05-01) -
Effect of a transtheoretical model-based intervention and motivational interviewing on hyperphosphatemia management via telehealth (TMT program) among hemodialysis patients during the COVID-19 pandemic
by: Arrom Thongsunti, et al.
Published: (2024-11-01) -
TWEAK promotes peritoneal inflammation.
by: Ana Belen Sanz, et al.
Published: (2014-01-01) -
TWEAK/Fn14 signaling in tumors
by: Guanglei Hu, et al.
Published: (2017-06-01) -
Sklerostin ve TWEAK’in Periodontitis Teşhisindeki Rolü
by: Gülay Tüter, et al.
Published: (2023-04-01)